Wird geladen...
Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
AIMS: Patients with adult congenital heart disease (ACHD) carry an increased risk for sudden cardiac death. Implantable cardioverter‐defibrillator (ICD) therapy may be challenging in these patients due to anatomical barriers, repeated cardiac surgery, or complicated transvenous access. Thus, the sub...
Gespeichert in:
| Veröffentlicht in: | ESC Heart Fail |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8006645/ https://ncbi.nlm.nih.gov/pubmed/33538124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13243 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|